Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

128

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change
25/06/26	€0.1830	+6.64%
24/06/26	€0.1716	+0.23%
23/06/26	€0.1712	-0.81%
22/06/26	€0.1726	-6.40%
19/06/26	€0.1844	-1.39%

Delayed Quote Börse Stuttgart

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Real-time Estimate Tradegate Other stock markets 08:19:13 25/06/2026 BST			5-day change	1st Jan Change
0.1830 ^EUR	+6.64%		-2.14%	-7.76%

06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT

Market Cap	56.49M 64.16M 52.1M 48.73M 91.3M 6.05B 93.01M 626M 243M 2.98B 241M 236M 10.38B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	56.61M 64.3M 52.22M 48.84M 91.5M 6.06B 93.21M 628M 243M 2.99B 241M 236M 10.4B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary
04-23	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
03-31	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
01-19	Klea Holding Increases Annual Revenue by 28%
01-19	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
01-19	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/10/25	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
27/10/25	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT
18/09/25	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
18/08/25	Klea Holding SA commences an Equity Buyback Plan for 30,751,431 shares, representing 10% of its issued share capital for ?46.13 million, under the authorization approved on June 10, 2025.	CI

06-11	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
04-23	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
04-23	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT
04-01	Klea Holding : Klea Holding is accelerating its diversification into the healthcare sector with the creation of Klea Pharmaceuticals	AT
01-19	Klea Holding : Klea Holding reports profitable growth of 34% in turnover in 2025 at constant exchange rates	AT

Klea Holding Share Price Börse Stuttgart

Stocks

7V91

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news : Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Course Extremes

Managers and Directors: Klea Holding

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

06-12	Klea Holding : Déclaration des transactions sur actions propres
06-11	Bourse : J-1 avant SpaceX, Oracle à la peine, contrat pour Airbus
06-11	Klea Holding annonce le démarrage de sa nouvelle filiale
06-11	Une bonne grosse purge avant SpaceX
06-11	Klea Holding : Klea Pharmaceuticals annonce le démarrage de son activité avec un puissant partenaire

1 day	+6.64%
1 week	-2.14%
Current month	-5.28%
1 month	+2.46%
3 months	+12.96%
6 months	-8.04%
Current year	-7.76%

1 week	0.17	0.19
1 month	0.17	0.2
Current year	0.15	0.25
1 year	0.15	0.25
3 years	0.15	0.4
5 years	0.15	0.54
10 years	0.15	2.03

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	21/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	31/03/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	31/03/2022
Paul Amsellem BRD	Director/Board Member	51	13/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	+6.64%	-2.14%	-	-	64.16M
CVS HEALTH CORPORATION	+0.30%	+2.73%	+50.74%	+46.36%	130B
HCA HEALTHCARE, INC.	+0.22%	-0.10%	+2.31%	+31.27%	86.02B
FRESENIUS SE & CO. KGAA	-1.19%	+0.84%	-5.51%	+60.23%	25.63B
QUEST DIAGNOSTICS INCORPORATED	+3.01%	+2.71%	+12.90%	+43.55%	22.48B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.05%	-1.83%	-18.03%	-26.68%	19.95B
TENET HEALTHCARE CORPORATION	+1.15%	+2.50%	+6.67%	+133.96%	15.76B
REDE D'OR SÃO LUIZ S.A.	-0.70%	+2.96%	-3.62%	+2.19%	14.38B
DAVITA INC.	+1.00%	+1.17%	+51.15%	+117.99%	13.68B
FRESENIUS MEDICAL CARE AG	-4.73%	-3.37%	-16.05%	-9.55%	12.86B
Average	+0.54%	+1.63%	+8.95%	+44.37%	37.86B
Weighted average by Cap.	+0.15%	+1.64%	+20.92%	+42.09%

	2024	2025
Net sales	17.26M 19.6M 15.92M 14.89M 27.9M 1.85B 28.42M 191M 74.11M 912M 73.61M 72.01M 3.17B	22.17M 25.18M 20.45M 19.12M 35.83M 2.37B 36.5M 246M 95.17M 1.17B 94.53M 92.48M 4.07B
Net income	1.4M 1.6M 1.3M 1.21M 2.27M 150M 2.31M 15.57M 6.03M 74.2M 5.99M 5.86M 258M	2.28M 2.59M 2.1M 1.97M 3.69M 244M 3.76M 25.28M 9.79M 120M 9.73M 9.52M 419M
Net Debt	2.58M 2.92M 2.38M 2.22M 4.16M 276M 4.24M 28.54M 11.06M 136M 10.98M 10.74M 473M	125K 142K 115K 108K 202K 13.38M 206K 1.39M 537K 6.6M 533K 522K 22.97M